Primary chemotherapy with or without colonic stent for management of irresectable stage IV colorectal cancer
Authors:
- M. KarouiMKM. Karoui
- A. SopraniASA. Soprani
- L. ViganoLVL. Vigano
- 31 January 2010
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 36 (1) , 58-64
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial TreatmentJournal of Clinical Oncology, 2009
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- Outcomes of resection and non-resection strategies in management of patients with advanced colorectal cancerWorld Journal of Surgical Oncology, 2009
- Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)Journal of Clinical Oncology, 2008
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Self-expanding Metallic Stents for Relieving Malignant Colorectal ObstructionAnnals of Surgery, 2007
- Asymptomatic Colorectal Cancer with Un-Resectable Liver Metastases: Immediate Colorectal Resection or Up-Front Systemic Chemotherapy?Annals of Surgical Oncology, 2006
- Epidemiology and Management of Liver Metastases From Colorectal CancerAnnals of Surgery, 2006
- Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2005
- Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by ChemotherapyAnnals of Surgery, 2004